StockStory.org on MSN

Why NeoGenomics (NEO) shares are falling today

What Happened? Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 10.1% in the afternoon session ...
Investing.com South Africa

NeoGenomics shares fall over 5% despite earnings beat

For the full year 2025, consolidated revenue increased 10% to $727 million, while the company reported a net loss of $108 million, up from $79 million in 2024. Adjusted EBITDA for 2025 was $43 million ...